BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells

Dan Zhu,1 Zongbin Sun,1 Jiayun Wei,2 Yulin Zhang,2 Wenjing An,2 Yan Lin,1 Xun Li1– 3 1First Clinical Medical College, Lanzhou University, Lanzhou, People’s Republic of China; 2Gansu Province Key Laboratory of Biotherapy and Regenerative Medicine, First Hospital of Lanzhou University, Lanzhou Univers...

Full description

Bibliographic Details
Main Authors: Zhu D, Sun Z, Wei J, Zhang Y, An W, Lin Y, Li X
Format: Article
Language:English
Published: Dove Medical Press 2024-04-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/bmp7-loaded-human-umbilical-cord-mesenchymal-stem-cell-derived-small-e-peer-reviewed-fulltext-article-IJN
_version_ 1797213858202386432
author Zhu D
Sun Z
Wei J
Zhang Y
An W
Lin Y
Li X
author_facet Zhu D
Sun Z
Wei J
Zhang Y
An W
Lin Y
Li X
author_sort Zhu D
collection DOAJ
description Dan Zhu,1 Zongbin Sun,1 Jiayun Wei,2 Yulin Zhang,2 Wenjing An,2 Yan Lin,1 Xun Li1– 3 1First Clinical Medical College, Lanzhou University, Lanzhou, People’s Republic of China; 2Gansu Province Key Laboratory of Biotherapy and Regenerative Medicine, First Hospital of Lanzhou University, Lanzhou University, Lanzhou, People’s Republic of China; 3General Surgery Department, First Hospital of Lanzhou University, Lanzhou University, Lanzhou, People’s Republic of ChinaCorrespondence: Xun Li, First Hospital of Lanzhou University, 1st West Donggang Road, Chengguan District, Lanzhou, Gansu Province, 730000, People’s Republic of China, Tel +86-931-8356056, Fax +86-931-8629797, Email lxdr21@126.comPurpose: Human umbilical cord mesenchymal stem cell (hucMSC)-derived small extracellular vesicles (sEVs) are natural nanocarriers with promising potential in treating liver fibrosis and have widespread applications in the fields of nanomedicine and regenerative medicine. However, the therapeutic efficacy of natural hucMSC-sEVs is currently limited owing to their non-specific distribution in vivo and partial removal by mononuclear macrophages following systemic delivery. Thus, the therapeutic efficacy can be improved through the development of engineered hucMSC-sEVs capable to overcome these limitations.Patients and Methods: To improve the anti-liver fibrosis efficacy of hucMSC-sEVs, we genetically engineered hucMSC-sEVs to overexpress the anti-fibrotic gene bone morphogenic protein 7 (BMP7) in parental cells. This was achieved using lentiviral transfection, following which BMP7-loaded hucMSC-sEVs were isolated through ultracentrifugation. First, the liver fibrosis was induced in C57BL/6J mice by intraperitoneal injection of 50% carbon tetrachloride (CCL4) twice a week for 8 weeks. These mice were subsequently treated with BMP7+sEVs via tail vein injection, and the anti-liver fibrosis effect of BMP7+sEVs was validated using small animal in vivo imaging, immunohistochemistry (IHC), tissue immunofluorescence, and enzyme-linked immunosorbent assay (ELISA). Finally, cell function studies were performed to confirm the in vivo results.Results: Liver imaging and liver histopathology confirmed that the engineered hucMSC-sEVs could reach the liver of mice and aggregate around activated hepatic stellate cells (aHSCs) with a significantly stronger anti-liver fibrosis effect of BMP7-loaded hucMSC-sEVs compared to those of blank or negative control-transfected hucMSC-sEVs. In vitro, BMP7-loaded hucMSC-sEVs promoted the phenotypic reversal of aHSCs and inhibited their proliferation to enhance the anti-fibrotic effects.Conclusion: These engineered BMP7-loaded hucMSC-sEVs offer a novel and promising strategy for the clinical treatment of liver fibrosis. Keywords: hucMSCs, sEVs, aHSCs, nanocarrier, BMP7
first_indexed 2024-04-24T11:04:57Z
format Article
id doaj.art-22f801b1ca954baa99e266fa615e88e3
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-04-24T11:04:57Z
publishDate 2024-04-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-22f801b1ca954baa99e266fa615e88e32024-04-11T18:05:51ZengDove Medical PressInternational Journal of Nanomedicine1178-20132024-04-01Volume 193475349591887BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate CellsZhu DSun ZWei JZhang YAn WLin YLi XDan Zhu,1 Zongbin Sun,1 Jiayun Wei,2 Yulin Zhang,2 Wenjing An,2 Yan Lin,1 Xun Li1– 3 1First Clinical Medical College, Lanzhou University, Lanzhou, People’s Republic of China; 2Gansu Province Key Laboratory of Biotherapy and Regenerative Medicine, First Hospital of Lanzhou University, Lanzhou University, Lanzhou, People’s Republic of China; 3General Surgery Department, First Hospital of Lanzhou University, Lanzhou University, Lanzhou, People’s Republic of ChinaCorrespondence: Xun Li, First Hospital of Lanzhou University, 1st West Donggang Road, Chengguan District, Lanzhou, Gansu Province, 730000, People’s Republic of China, Tel +86-931-8356056, Fax +86-931-8629797, Email lxdr21@126.comPurpose: Human umbilical cord mesenchymal stem cell (hucMSC)-derived small extracellular vesicles (sEVs) are natural nanocarriers with promising potential in treating liver fibrosis and have widespread applications in the fields of nanomedicine and regenerative medicine. However, the therapeutic efficacy of natural hucMSC-sEVs is currently limited owing to their non-specific distribution in vivo and partial removal by mononuclear macrophages following systemic delivery. Thus, the therapeutic efficacy can be improved through the development of engineered hucMSC-sEVs capable to overcome these limitations.Patients and Methods: To improve the anti-liver fibrosis efficacy of hucMSC-sEVs, we genetically engineered hucMSC-sEVs to overexpress the anti-fibrotic gene bone morphogenic protein 7 (BMP7) in parental cells. This was achieved using lentiviral transfection, following which BMP7-loaded hucMSC-sEVs were isolated through ultracentrifugation. First, the liver fibrosis was induced in C57BL/6J mice by intraperitoneal injection of 50% carbon tetrachloride (CCL4) twice a week for 8 weeks. These mice were subsequently treated with BMP7+sEVs via tail vein injection, and the anti-liver fibrosis effect of BMP7+sEVs was validated using small animal in vivo imaging, immunohistochemistry (IHC), tissue immunofluorescence, and enzyme-linked immunosorbent assay (ELISA). Finally, cell function studies were performed to confirm the in vivo results.Results: Liver imaging and liver histopathology confirmed that the engineered hucMSC-sEVs could reach the liver of mice and aggregate around activated hepatic stellate cells (aHSCs) with a significantly stronger anti-liver fibrosis effect of BMP7-loaded hucMSC-sEVs compared to those of blank or negative control-transfected hucMSC-sEVs. In vitro, BMP7-loaded hucMSC-sEVs promoted the phenotypic reversal of aHSCs and inhibited their proliferation to enhance the anti-fibrotic effects.Conclusion: These engineered BMP7-loaded hucMSC-sEVs offer a novel and promising strategy for the clinical treatment of liver fibrosis. Keywords: hucMSCs, sEVs, aHSCs, nanocarrier, BMP7https://www.dovepress.com/bmp7-loaded-human-umbilical-cord-mesenchymal-stem-cell-derived-small-e-peer-reviewed-fulltext-article-IJNhucmscssevsahscsnanocarrierbmp7
spellingShingle Zhu D
Sun Z
Wei J
Zhang Y
An W
Lin Y
Li X
BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
International Journal of Nanomedicine
hucmscs
sevs
ahscs
nanocarrier
bmp7
title BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
title_full BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
title_fullStr BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
title_full_unstemmed BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
title_short BMP7-Loaded Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorate Liver Fibrosis by Targeting Activated Hepatic Stellate Cells
title_sort bmp7 loaded human umbilical cord mesenchymal stem cell derived small extracellular vesicles ameliorate liver fibrosis by targeting activated hepatic stellate cells
topic hucmscs
sevs
ahscs
nanocarrier
bmp7
url https://www.dovepress.com/bmp7-loaded-human-umbilical-cord-mesenchymal-stem-cell-derived-small-e-peer-reviewed-fulltext-article-IJN
work_keys_str_mv AT zhud bmp7loadedhumanumbilicalcordmesenchymalstemcellderivedsmallextracellularvesiclesameliorateliverfibrosisbytargetingactivatedhepaticstellatecells
AT sunz bmp7loadedhumanumbilicalcordmesenchymalstemcellderivedsmallextracellularvesiclesameliorateliverfibrosisbytargetingactivatedhepaticstellatecells
AT weij bmp7loadedhumanumbilicalcordmesenchymalstemcellderivedsmallextracellularvesiclesameliorateliverfibrosisbytargetingactivatedhepaticstellatecells
AT zhangy bmp7loadedhumanumbilicalcordmesenchymalstemcellderivedsmallextracellularvesiclesameliorateliverfibrosisbytargetingactivatedhepaticstellatecells
AT anw bmp7loadedhumanumbilicalcordmesenchymalstemcellderivedsmallextracellularvesiclesameliorateliverfibrosisbytargetingactivatedhepaticstellatecells
AT liny bmp7loadedhumanumbilicalcordmesenchymalstemcellderivedsmallextracellularvesiclesameliorateliverfibrosisbytargetingactivatedhepaticstellatecells
AT lix bmp7loadedhumanumbilicalcordmesenchymalstemcellderivedsmallextracellularvesiclesameliorateliverfibrosisbytargetingactivatedhepaticstellatecells